By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...

New Delhi: In a move to spur drug innovation and restore fairness in the regulatory ecosystem, India’s top drug authority plans to overhaul a rule that puts early applicants for new medicines at a ...

A new project seeking to transform the drug delivery process and take projects out of “the valley of death” between aspiration and accomplishment is getting help from La Jolla-based medical research ...

Meanwhile, a total of 76 innovative medical devices, of which 80 percent were domestically developed, were granted market ...

“There are over 600,000 drugs in the Korea Chemical Bank alone. It felt overwhelming to find a drug that perfectly fits the protein structure we’re targeting among them. That’s when I thought of AI ...

Pharmaceutical innovation saves lives. But not every "new" drug is truly new. Such practices raise concerns about drug access and affordability, especially when companies use minor tweaks to block ...

Government regulations affect drug development, often prolonging the process, but they ensure safety and efficacy to protect public health. Here's how.